✦ LIBER ✦

Exfoliative Dermatitis Following Intravesical Therapy with Mitomycin C

✍ Scribed by P. L. Bencini; F. Sala; C. Crosti; M. Nobili; E. Bertani

Book ID: 110096365
Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 425 KB
Volume: 24
Category: Article
ISSN: 0011-9059
DOI: 10.1111/j.1365-4362.1985.tb05532.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Exfoliative Dermatitis Following lntrave

Exfoliative Dermatitis Following lntravesical Therapy with Mitomycin C

✍ P. L. Bencini; F. Sala; C. Crosti; M. Nobili; E. Bertani 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

Skin rash following therapy with mitomyc

Skin rash following therapy with mitomycin C

✍ Paul S. Ritch; Arthur C. Louie 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Detecting mitomycin C in human plasma du

Detecting mitomycin C in human plasma during intravesical therapy

✍ K. Jauhiainen 📂 Article 📅 1985 🏛 Springer Netherlands 🌐 English ⚖ 239 KB

Behavior and resorption of mitomycin C f

Behavior and resorption of mitomycin C following multiple intravesical administrations

✍ P. J. R. O. Van Helsdingen; E. A. de Bruijn; H. P. Sleeboom; C. H. M. Rikken; U. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 483 KB

Systemic allergic contact dermatitis fro

Systemic allergic contact dermatitis from intravesical instillation of the antitumor antibiotic mitomycin C

✍ Anton C. de Groot; Jean M. H. Conemans 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 950 KB

Prophylactic intravesical instillation t

Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer

✍ Tomoyasu Tsushima; Yosuke Matsumura; Yujiro Ozaki; Jun Yoshimoto; Hiroyuki Ohmor 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 380 KB

Intravesical instillation of adriamycin (ADM) or mitomycin C (MMC) was carried out for the purpose of preventing the recurrence of superficial bladder cancers (Ta and T1) after transurethral resection or transurethral coagulation. First, eligible patients were divided into two groups (solitary and m